orbifloxacin 30 mg/ml - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

orbax flavoured oral suspension 30 mg/ml for dogs

schering plough limited - orbifloxacin, micronised - oral suspension - 30 mg/ml - canine - antibacterial

Philippines - English - FDA (Food And Drug Administration)

orbax 30 mg/ml oral suspension

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - orbifloxacin (vet.) - oral suspension - 30 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

orbax flavoured oral suspension 30 mg/ml for dogs and cats

intervet ireland limited - orbifloxacin, micronised - oral suspension - 30 mg/ml - antibacterial - canine feline

United States - English - NLM (National Library of Medicine)

orbax- orbifloxacin tablet, coated

merck sharp & dohme corp. - orbifloxacin (unii: 660932tpy6) (orbifloxacin - unii:660932tpy6) - orbifloxacin 22.7 mg - indications: orbax® (orbifloxacin) tablets are indicated for the management of diseases in dogs and cats associated with bacteria susceptible to orbifloxacin. contraindications: orbifloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. orbifloxacin is contraindicated in immature dogs during the rapid growth phase (between 2 and 8 months of age in small and medium-sized breeds, and up to 18 months of age in large and giant breeds). orbifloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

orbax flavoured oral suspension 30 mg/ml for dogs and cats

msd animal health uk limited - orbifloxacin - oral suspension - antimicrobial - cats, dogs